Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · IEX Real-Time Price · USD
2.270
-0.080 (-3.40%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Lumos Pharma Market Cap
Lumos Pharma has a market cap or net worth of $18.42 million as of July 2, 2024. Its market cap has decreased by -39.99% in one year.
Market Cap
18.42M
Enterprise Value
-4.24M
1-Year Change
-39.99%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since November 11, 2011, Lumos Pharma's market cap has decreased from $127.60M to $18.42M, a decrease of -85.56%. That is a compound annual growth rate of -14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 18.40M | -26.98% |
| Dec 29, 2023 | 25.20M | -16.56% |
| Dec 30, 2022 | 30.20M | -47.84% |
| Dec 31, 2021 | 57.90M | -80.46% |
| Dec 31, 2020 | 296.30M | 213.88% |
| Dec 31, 2019 | 94.40M | 66.78% |
| Dec 31, 2018 | 56.60M | -81.18% |
| Dec 29, 2017 | 300.70M | 0.40% |
| Dec 30, 2016 | 299.50M | -71.41% |
| Dec 31, 2015 | 1.05B | -5.75% |
| Dec 31, 2014 | 1.11B | 96.43% |
| Dec 31, 2013 | 565.80M | 116.45% |
| Dec 31, 2012 | 261.40M | 80.28% |
| Dec 30, 2011 | 145.00M | 13.64% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kala Pharmaceuticals | 18.90M |
| MEI Pharma | 18.66M |
| Ekso Bionics Holdings | 18.64M |
| BriaCell Therapeutics | 18.47M |
| Indaptus Therapeutics | 18.44M |
| Unicycive Therapeutics | 18.05M |
| Iterum Therapeutics | 18.04M |
| Senti Biosciences | 17.84M |